Likewise, CSF tau measured at diagnosis correlates with short-term disability progression (Multiple Sclerosis Severity Score—MSSS), underscoring its role as a prognostic indicator of neurodegeneration [78]. This evidence concerns the gene MAPT and multiple sclerosis.